Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells
- 16 July 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 374 (2) , 258-263
- https://doi.org/10.1016/j.bbrc.2008.07.031
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signalingBiochemical and Biophysical Research Communications, 2008
- Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cellsBritish Journal of Pharmacology, 2008
- Autophagy fights disease through cellular self-digestionNature, 2008
- Proteasome inhibitor, bortezomib, for myeloma and lymphomaInternational Journal of Clinical Oncology, 2007
- Linking of Autophagy to Ubiquitin-Proteasome System Is Important for the Regulation of Endoplasmic Reticulum Stress and Cell ViabilityThe American Journal of Pathology, 2007
- Incorporating Bortezomib into the Treatment of Lung CancerClinical Cancer Research, 2007
- HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPSNature, 2007
- The roles of intracellular protein-degradation pathways in neurodegenerationNature, 2006
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000
- Proteasome-Dependent Regulation of p21WAF1/CIP1ExpressionBiochemical and Biophysical Research Communications, 1996